Elisabeth Ralfkiaer
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma.
Journal: Leukemia & lymphoma
Published: May 03, 2018
Heading for centennial anniversary and beyond.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: December 02, 2017
Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
Journal: JAMA ophthalmology
Published: November 10, 2017
Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma.
Journal: American journal of hematology
Published: January 05, 2017
Lymphoma of the Eyelid - An International Multicenter Retrospective Study.
Journal: American journal of ophthalmology
Published: November 21, 2016
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: November 04, 2016
TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides.
Journal: Frontiers in medicine
Published: June 13, 2016
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Journal: Acta neuropathologica communications
Published: March 27, 2016
STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Journal: Oncotarget
Published: March 23, 2016
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
Journal: British journal of haematology
Published: March 17, 2016
Last Updated: 09/26/2026